Elevation of IGF-2 receptor and the possible underlying implications in end-stage heart failure patients before and after heart transplantation

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 5, 2012, Pages 1038-1046

  Wei, Yingjie ^a   Li, Jun ^a   Huang, Jie ^a   Zhang, Xiaoling ^a   Zhao, Hong ^a   Cui, Chuanjue ^a   Li, Yishi ^a   Hu, Shengshou ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Acute cellular rejection; Apoptosis; End stage heart failure; Heart transplantation; Insulin like growth factor 2 receptor

Indexed keywords

CD8 ANTIGEN; GRANZYME; INTERLEUKIN 2; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN B RECEPTOR;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; DNA STRAND BREAKAGE; DRUG EFFECT; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; RAT; UPREGULATION;

ANIMALS; ANTIGENS, CD8; APOPTOSIS; DNA BREAKS; FEMALE; GRANZYMES; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; RATS; REACTIVE OXYGEN SPECIES; RECEPTOR, IGF TYPE 2; UP-REGULATION;

RATTUS;

EID: 84860341544     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01414.x     Document Type: Article

References (35)

1. Hawkes C, Jhamandas JH, Harris KH, et al. Single transmembrane domain insulin-like growth factor-II/mannose-6-phosphate receptor regulates central cholinergic function by activating a G-protein sensitive, protein kinase C-dependent pathway. J Neurosci. 2006; 26: 585-96.
2. Kang JX, Bell J, Beard RL, et al. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids. Cell Growth Differ. 1999; 10: 591-600.
3. Blanchard F, Duplomb L, Raher S, et al. Mannose 6-phosphate/insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction. J Biol Chem. 1999; 274: 24685-93.
4. Lee SJ, Nathans D. Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors. J Biol Chem. 1988; 263: 3521-7.
5. Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A. 1991; 88: 580-4.
6. van Kesteren CAM, Danser AHJ, Derkx FHM, et al. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension. 1997; 30: 1389-96.
7. Chen Z, Ge Y, Kang JX. Down-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes. BMC Cell Biol. 2004; 5: 15.
8. Chang MH, Kuo WW, Chen RJ, et al. IGF-II/Mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plaminogen activator expression inH9c2 cardiomyoblast cells. J Mol Endocrinol. 2008; 41: 65-74.
9. Nissley P, Kiess W, Skler M. Developmental expression of the IGF-II/Mannose 6-phosphate receptor. Mol Reprod Dev. 1993; 35: 408-13.
10. Lau MM, Stewart CE, Liu Z, et al. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in foetal overgrowth and perinatal lethality. Genes Dev. 1994; 8: 2953-63.
11. Huang CY, Hao LY, Buetow DE. Hypertrophy of cultured adult rat ventricular cardiomyocytes induced by antibodies against the insulin-like growth factor (IGF)-I or the IGF-I receptor is IGF-II-dependent. Mol Cell Biochem. 2002; 233: 65-72.
12. Chu CH, Tzang BS, Chen LM, et al. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Gaq interaction and protein kinase C-a/CaMKII activation in H9c2 cardiomyoblast cells. J Endocrinol. 2008; 197: 381-90.
13. Lee SD, Chu CH, Huang EJ, et al. Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Am J Physiol Endocrinol Metab. 2006; 291: E306-14.
14. Motyka B, Korbutt G, Pinkoski MJ, et al. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell. 2000; 103: 491-500.
15. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990; 9: 587-93.
16. Seeland U, Selejan S, Engelhardt S, et al. Interstitial remodeling in β1-adrenergic receptor transgenic mice. Basic Res Cardiol 2007; 102: 183-93.
17. Jeyaseelan R, Poizat C, Baker RK, et al. A novel cardiac-restricted target for doxorubicin. J Biol Chem. 1997; 272: 22800-8.
18. Chu CH, Tzang BS, Chen LM, et al. Activation of insulin-like growth factor II receptor induces mitochondrial-dependent apoptosis through G_q and downstream calcineurin signaling in myocardial cells. Endocrinology. 2009; 150: 2723-31.
19. ATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol. 2006; 291: H2067-74.
20. Wei Y, Cui C, Lainscak M, et al. Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients. J Cell Mol Med. 2011; 15: 773-82.
21. Causin C, Waheed A, Braulke T, et al. Mannose 6-phosphate/insulin-like growth factor-II binding proteins in human serum and urine. Biochem J. 1988; 252: 795-9.
22. Kang PM, Izumo S. Apoptosis and heart failure: a critical review of the literature. Circ Res. 2000; 86: 1107-13.
23. Grieve DJ, Shah AM. Oxidative stress in heart failure. Eur Heart J. 2003; 24: 2161-3.
24. Shizukuda Y, Buttrick PM. Oxygen free radicals and heart failure: new insight into an old question. Am J Physiol Lung Cell Mol Physiol. 2002; 283: L237-8.
25. Byrne JA, Grieve DJ, Cave AC, et al. Oxidative stress and heart failure. Arch Mal Coeur Vaiss. 2003; 96: 214-21.
26. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005; 115: 500-8.
27. Singal PK, Khaper N, Palace V, et al. The role of oxidative stress in the genesis of heart disease. Cardiovas Res. 1998; 40: 426-32.
28. Hunt SA. Complications of heart transplantation. J Heart Transplant 1983; 3: 70-8.
29. Hameed A, Truong LD, Price V, et al. Immunohistochemical localization of granzyme B antigen in cytotoxic cells in human tissues. Am J Pathol. 1991; 138: 1069-75.
30. Clement MV, Haddad P, Soulie A, et al. Perforin and granzyme B as markers for acute rejection in heart transplantation. Int Immunol. 1991; 3: 1175-81.
31. Bruce Motyka B, Korbutt G, Pinkoski MJ, et al. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic t cell-induced apoptosis. Cell. 2000; 103: 491-500.
32. Veugelers K, Motyka B, Goping IS, et al. Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate. Mol Biol Cell. 2006; 17: 623-33.
33. Kubo SH, Naftel DC, Mills RM Jr, et al. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. J Heart Lung Transplant. 1995; 14: 409-18.
34. Ho AD, Maruyama M, Maghazachi A, et al. Corringham RET: soluble CD4, soluble CD8, soluble CD25, lymphopoetic recovery and endogenous cytokines after high dose chemotherapy and blood stem cell transplantation. Blood. 1994; 84: 3550-7.
35. Willsie SK, Herndon BL, Miller L, et al. Soluble versus cell-bound CD4, CD8 from bronchoalveolar lavage: correlation with pulmonary diagnoses in human immunodeficiency virus-infected individuals. J Leukocyte Biol. 1996; 59: 813-6.